GO:0012502 induction of programmed cell death: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0012502 (induction of programmed cell death) describes the upstream process that directly activates the molecular steps required for programmed cell death, distinct from the execution phase itself.
• Induction can be triggered by diverse stimuli including synthetic biology tools, natural compounds, viral infection, and cellular stress, and can channel cells toward apoptosis, ferroptosis, or other regulated death programs [1,2,3,4].
• Ferroptosis has emerged as a prominently enriched programmed cell death process in specific pathological contexts such as hemorrhage stroke-induced white matter injury.
• Natural compounds such as nobiletin and apigenin act as inducers of programmed cell death in cancer, highlighting the chemopreventive and therapeutic relevance of this GO term [3,4].
• Viral pathogens including influenza and dengue virus can actively induce programmed cell death as part of pathogenesis [6,7].
• Hematopoietic stem cells are sensitive to programmed cell death pathways, with both lethal and sublethal effects influencing stem cell biology.
Description
Programmed cell death is a genetically encoded, actively regulated process essential for development, tissue homeostasis, and defense against pathogens. The Gene Ontology term GO:0012502, induction of programmed cell death, captures the upstream events that directly activate any of the steps required for programmed cell death, distinguishing the triggering phase from the downstream execution machinery. This term is critical for researchers because the decision to die, rather than the death itself, often determines therapeutic outcomes in cancer, infection, and degenerative disease. Understanding how programmed cell death is induced provides a conceptual framework for interpreting single-cell transcriptomics, genetic screens, and pharmacological studies [2,3]. Recent advances in synthetic biology have enabled selective induction of specific programmed cell death modalities, underscoring the growing importance of this ontology term in both basic and translational research. As the field moves toward precision manipulation of cell death, GO:0012502 serves as a key annotation for genes and pathways that initiate, rather than merely execute, cellular suicide programs [1,5].
induction of programmed cell death At A Glance
| GO ID | GO:0012502 |
|---|---|
| GO term | induction of programmed cell death |
| Ontology | biological_process |
| Synonym | induction of non-apoptotic programmed cell death; induction of nonapoptotic programmed cell death |
| Definition | A process which directly activates any of the steps required for programmed cell death. |
| Major function | Triggering the molecular cascade that commits a cell to programmed cell death |
| Related processes | Apoptosis, ferroptosis, necroptosis, pyroptosis, and other regulated cell death modalities |
| Research relevance | Cancer therapy, chemoprevention, viral pathogenesis, stem cell biology, and neurodegeneration |
What Is GO:0012502?
According to the Gene Ontology, GO:0012502 (induction of programmed cell death) is a biological process defined as a process which directly activates any of the steps required for programmed cell death. In other words, it encompasses the molecular events that trigger or initiate the programmed cell death cascade, rather than the downstream effector steps that carry out the death program. The term includes synonyms such as induction of non-apoptotic programmed cell death and induction of nonapoptotic programmed cell death, reflecting its applicability to multiple regulated cell death modalities beyond classical apoptosis.
Why Is induction of programmed cell death Important in Cell Biology?
GO:0012502 is important because the induction phase of programmed cell death represents a decisive regulatory checkpoint that determines whether a cell survives or dies. Many human diseases, including cancer, viral infections, and degenerative disorders, involve dysregulation at the level of death induction rather than execution. For example, cancer cells often evade or resist pro-death signals, while excessive induction contributes to tissue damage in stroke and infection [2,6]. Understanding the molecular players that directly activate programmed cell death enables the design of targeted therapeutic strategies, including synthetic biology tools that selectively induce specific death modalities. Moreover, the term provides a standardized annotation for genes and pathways that function upstream in the death cascade, facilitating comparative genomics and functional enrichment analyses [2,3].
• Defines the upstream trigger point for all programmed cell death modalities, enabling precise annotation of initiating genes.
• Central to cancer research, where induction of programmed cell death by natural compounds such as nobiletin and apigenin offers chemopreventive potential [3,4].
• Implicated in hemorrhage stroke, where ferroptosis is the most enriched programmed cell death process in oligodendrocyte-mediated white matter injury.
• Critical for understanding viral pathogenesis, as influenza and dengue virus induce programmed cell death in host cells [6,7].
• Relevant to hematopoietic stem cell biology, where lethal and sublethal programmed cell death effects influence stem cell fate.
• Provides a conceptual basis for synthetic biology approaches that selectively induce specific cell death programs.
• Supports single-cell and spatial transcriptomics analyses by enabling enrichment of programmed cell death processes.
• Facilitates identification of therapeutic targets that modulate the threshold for death induction in disease.
• Helps distinguish initiating events from execution events in mechanistic studies of cell death.
• Enables cross-species and cross-disease comparisons of death induction pathways through standardized GO annotation.
What Happens During induction of programmed cell death?
Recognition of Pro-Death Stimuli
In simple terms: The cell senses a signal that tells it to die.
The induction of programmed cell death begins when a cell receives or perceives a pro-death stimulus. Such stimuli can be extrinsic, including viral infection, synthetic biology tools, or natural compounds, or intrinsic, such as cellular stress or developmental cues [1,3,4]. For example, nobiletin and apigenin act as inducers of programmed cell death in cancer cells, triggering the death cascade through specific molecular interactions [3,4]. In the context of viral infection, influenza and dengue virus can directly induce programmed cell death as part of their pathogenesis [6,7]. The recognition step is critical because it determines whether the cell commits to death and which modality is activated.
Signal Transduction to Death Machinery
In simple terms: The death signal is passed along a chain of molecular messengers.
Once a pro-death stimulus is recognized, intracellular signaling pathways transduce the signal to the core death machinery. This step involves activation or deactivation of specific kinases, phosphatases, and adaptor proteins that directly activate the steps required for programmed cell death. Synthetic biology tools have been developed to selectively induce programmed cell death by engineering these signaling components, demonstrating that the induction phase is amenable to precise manipulation. In hemorrhage stroke, single-cell and spatial transcriptomics revealed that ferroptosis is the most enriched programmed cell death process in oligodendrocytes, indicating that specific signaling routes dominate in particular pathological contexts. The signal transduction phase is therefore a key determinant of death modality specificity [1,2].
Commitment and Activation of Executioner Modules
In simple terms: The cell makes an irreversible decision to die and activates the death executioners.
Following signal transduction, the cell reaches a commitment point where executioner modules are directly activated. This activation is the defining feature of GO:0012502, as the term requires direct activation of steps required for programmed cell death. In cancer biology, induction of programmed cell death by compounds such as nobiletin leads to activation of executioner caspases and other death effectors. Similarly, apigenin-induced programmed cell death involves commitment to apoptosis through mitochondrial and other pathways. The commitment step is often regulated by checkpoints that integrate pro-survival and pro-death signals, and its dysregulation is a hallmark of cancer and other diseases.
Modality Selection: Apoptosis, Ferroptosis, and Beyond
In simple terms: The cell chooses which type of death program to run.
Induction of programmed cell death is not limited to apoptosis; it encompasses non-apoptotic modalities as reflected in the synonyms of GO:0012502. Ferroptosis, for instance, is a prominent programmed cell death process in hemorrhage stroke-induced white matter injury, where it is the most enriched death pathway in oligodendrocytes. Other modalities include necroptosis and pyroptosis, each with distinct inducing signals and molecular players [1,5]. The selection of death modality depends on the nature of the stimulus, the cellular context, and the availability of specific executioner proteins. Understanding modality selection is essential for designing therapies that preferentially induce a desired form of cell death [1,5].
Integration with Cellular Stress and Survival Pathways
In simple terms: The death decision is balanced against survival signals.
The induction of programmed cell death is tightly integrated with cellular stress and survival pathways. For example, hematopoietic stem cells exhibit lethal and sublethal effects of programmed cell death pathways, indicating that the balance between survival and death signaling is critical for stem cell maintenance. In cancer, cell death pathways are often rewired to favor survival, and understanding how induction signals are integrated with oncogenic and stress pathways is a major research focus. Viral infections such as influenza and dengue can tip this balance toward death, contributing to pathogenesis [6,7]. Thus, the induction phase serves as an integration hub for diverse cellular inputs [1,5,8].
Key Genes Involved in GO:0012502 induction of programmed cell death
The following genes and proteins are representative molecular players involved in the induction of programmed cell death, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Transcription factor that induces pro-apoptotic genes in response to stress | Central to cancer research and induction of apoptosis |
| BCL2 | Anti-apoptotic protein that inhibits induction of programmed cell death | Target for cancer therapy and apoptosis regulation |
| BAX | Pro-apoptotic effector that promotes mitochondrial outer membrane permeabilization | Key marker of apoptosis induction |
| CASP3 | Executioner caspase activated downstream of death induction | Readout of apoptosis induction |
| CASP8 | Initiator caspase in extrinsic apoptosis pathway | Mediator of death receptor-induced apoptosis |
| FADD | Adaptor protein linking death receptors to caspase activation | Component of extrinsic death induction |
| RIPK1 | Kinase involved in necroptosis induction | Regulator of non-apoptotic programmed cell death |
| RIPK3 | Kinase essential for necroptosis execution | Modality-specific death induction |
| MLKL | Executioner of necroptosis | Downstream effector of necroptosis induction |
| GPX4 | Glutathione peroxidase that protects against ferroptosis | Negative regulator of ferroptosis induction |
| ACSL4 | Enzyme that promotes lipid peroxidation in ferroptosis | Positive regulator of ferroptosis induction |
| SLC7A11 | Cystine/glutamate antiporter that suppresses ferroptosis | Modulator of ferroptosis sensitivity |
| NLRP3 | Inflammasome sensor that induces pyroptosis | Mediator of inflammatory cell death induction |
| GSDMD | Gasdermin pore-forming protein in pyroptosis | Executioner of pyroptosis downstream of induction |
| BID | BH3-only protein linking extrinsic and intrinsic apoptosis | Amplifier of death induction |
| PMAIP1 | BH3-only protein induced by p53 | Mediator of stress-induced apoptosis |
| BBC3 | BH3-only protein that promotes apoptosis | Regulator of death induction in cancer |
How Is induction of programmed cell death Regulated?
The induction of programmed cell death is regulated at multiple levels, including transcriptional control of pro- and anti-apoptotic genes, post-translational modifications of death machinery components, and integration with cellular stress and survival pathways [1,5]. For example, the balance between BCL2 family members determines mitochondrial outer membrane permeabilization and commitment to apoptosis. In ferroptosis, GPX4 and SLC7A11 act as negative regulators, while ACSL4 promotes lipid peroxidation and death induction. Synthetic biology tools have been engineered to selectively regulate death induction pathways, demonstrating that these regulatory nodes are amenable to precise control. Additionally, hematopoietic stem cells exhibit context-dependent regulation of death pathways, with both lethal and sublethal outcomes depending on the strength and duration of the inducing signal.
induction of programmed cell death and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Cancer (tumor suppression via apoptosis induction) | TP53 knockout and point-mutation cell lines |
| GPX4 | Ferroptosis in stroke and cancer | GPX4 knockout and overexpression models |
| ACSL4 | Ferroptosis sensitivity in white matter injury | ACSL4 knockout oligodendrocyte models |
| RIPK3 | Necroptosis in inflammatory diseases | RIPK3 knockout and kinase-dead knock-in |
| CASP8 | Apoptosis in cancer and immune disorders | CASP8 knockout and point-mutation models |
Cancer
Dysregulation of programmed cell death induction is a hallmark of cancer, where tumor cells often evade or resist pro-death signals. Natural compounds such as nobiletin and apigenin have been shown to induce programmed cell death in cancer cells, highlighting their chemopreventive and therapeutic potential [3,4]. Understanding the molecular mechanisms of death induction in cancer can inform the development of targeted therapies that restore the cell's ability to undergo programmed death.
Hemorrhage Stroke and White Matter Injury
In hemorrhage stroke, ferroptosis is the most enriched programmed cell death process in oligodendrocyte-mediated white matter injury, as revealed by single-cell and spatial transcriptomics. This finding underscores the importance of death induction pathways in neuronal and glial pathology and suggests that targeting ferroptosis induction may be a therapeutic strategy for stroke.
Viral Pathogenesis
Influenza and dengue virus can induce programmed cell death in host cells, contributing to tissue damage and disease severity [6,7]. The induction of death by these viruses involves specific viral and host factors, and understanding these mechanisms may inform antiviral strategies [6,7].
Hematopoietic Stem Cell Biology
Programmed cell death pathways have lethal and sublethal effects on hematopoietic stem cells, influencing their survival, proliferation, and differentiation. This has implications for bone marrow failure, leukemia, and stem cell transplantation.
From induction of programmed cell death-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene directly induce programmed cell death? | CRISPR knockout in cancer cell lines followed by death assays |
| Which point mutations in a death effector alter induction? | CRISPR point-mutation knock-in of specific residues |
| Can a synthetic construct selectively induce ferroptosis? | CRISPR knock-in of inducible synthetic circuits |
| How does a gene's expression level affect death sensitivity? | CRISPR overexpression and knockout models |
| What is the role of a gene in stem cell death? | CRISPR knockout in hematopoietic stem cells |
| Which genes are essential for death induction in a disease model? | Genome-wide CRISPR library screening |
How to Study the induction of programmed cell death Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Transcriptomic profiles of individual cells | Identifying enriched death processes in disease |
| Spatial transcriptomics | Gene expression with spatial context | Mapping death induction in tissue architecture |
| CRISPR knockout screening | Gene essentiality for death induction | Discovering novel regulators of programmed cell death |
| Caspase activity assay | Executioner caspase activation | Quantifying apoptosis induction |
| Lipid peroxidation assay | Ferroptosis induction | Measuring ferroptosis in stroke models |
| Viability assay | Cell survival after death stimulus | Screening inducers of programmed cell death |
| Synthetic biology reporters | Selective induction of death modalities | Precise manipulation of death pathways |
| Flow cytometry | Apoptotic and necrotic cell populations | Characterizing death modality |
Single-Cell and Spatial Transcriptomics
Single-cell and spatial transcriptomics enable the identification of enriched programmed cell death processes in specific cell types and tissues. For example, this approach revealed ferroptosis as the most enriched programmed cell death process in hemorrhage stroke-induced oligodendrocyte-mediated white matter injury. These methods are powerful for discovering which death modalities are induced in complex pathological contexts.
CRISPR Screening
Genome-wide CRISPR knockout and activation screens can identify genes that are essential for or that suppress the induction of programmed cell death. Such screens are particularly useful for uncovering novel regulators of death induction pathways [1,5].
Cell Death Assays
Standard cell death assays, including viability assays, caspase activity assays, and lipid peroxidation measurements, are used to quantify the induction of programmed cell death in response to stimuli such as nobiletin, apigenin, or viral infection [3,4,6,7].
Synthetic Biology Tools
Synthetic biology tools have been developed to selectively induce programmed cell death, allowing precise control over the timing and modality of death induction. These tools are valuable for dissecting the molecular steps of GO:0012502.
How CRISPR Can Be Used to Study GO:0012502 induction of programmed cell death
Knockout
CRISPR knockout is used to delete genes suspected of inducing programmed cell death, allowing researchers to test whether loss of the gene prevents or delays death induction. For example, knocking out GPX4 sensitizes cells to ferroptosis, while knocking out ACSL4 confers resistance. Knockout models are essential for establishing causality in death induction pathways.
Point Mutation
CRISPR point mutation knock-in enables the introduction of specific amino acid substitutions to study the function of individual residues in death-inducing proteins. This is particularly useful for dissecting kinase domains, phosphorylation sites, and interaction interfaces in proteins such as RIPK1 and RIPK3.
Knock-in
CRISPR knock-in can be used to insert reporter genes, tags, or synthetic inducible cassettes into endogenous loci to monitor or control the induction of programmed cell death. For example, knock-in of a fluorescent reporter downstream of a death-inducing gene allows real-time tracking of death induction.
Overexpression
CRISPR overexpression models, often achieved via CRISPR activation (CRISPRa), are used to increase the expression of candidate genes to test whether elevated levels are sufficient to induce programmed cell death. This approach is valuable for studying pro-death genes that are normally kept at low levels [1,5].
How EDITGENE Supports induction of programmed cell death Research
Researchers studying induction of programmed cell death-related genes often need to determine whether a candidate gene is causally involved in triggering the death cascade, which death modality it activates, and how its activity can be modulated for therapeutic benefit. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for induction of programmed cell death research.
Frequently Asked Questions About induction of programmed cell death
What is GO:0012502 induction of programmed cell death?
GO:0012502 is a Gene Ontology biological process term defined as a process which directly activates any of the steps required for programmed cell death. It covers the triggering phase of cell death, including apoptosis and non-apoptotic modalities.
What genes are involved in induction of programmed cell death?
Key genes include TP53, BCL2, BAX, CASP3, CASP8, FADD, RIPK1, RIPK3, MLKL, GPX4, ACSL4, SLC7A11, NLRP3, GSDMD, BID, PMAIP1, and BBC3, as supported by the cited literature [1,2,3,4,5].
How is programmed cell death induced in cancer?
Natural compounds such as nobiletin and apigenin can induce programmed cell death in cancer cells, and synthetic biology tools have been developed to selectively trigger specific death modalities [1,3,4].
What is the role of ferroptosis in stroke?
Single-cell and spatial transcriptomics revealed that ferroptosis is the most enriched programmed cell death process in hemorrhage stroke-induced oligodendrocyte-mediated white matter injury.
Can viruses induce programmed cell death?
Yes, influenza and dengue virus can induce programmed cell death in host cells as part of their pathogenesis [6,7].
What are the synonyms of GO:0012502?
The synonyms are induction of non-apoptotic programmed cell death and induction of nonapoptotic programmed cell death.
How do hematopoietic stem cells respond to programmed cell death?
Programmed cell death pathways have both lethal and sublethal effects on hematopoietic stem cells, influencing their survival and function.
What research methods are used to study induction of programmed cell death?
Methods include single-cell and spatial transcriptomics, CRISPR screening, cell death assays, and synthetic biology tools [1,2,3,4].
What is the difference between induction and execution of programmed cell death?
Induction refers to the upstream events that directly activate the death cascade, while execution refers to the downstream steps that carry out cell death. GO:0012502 specifically covers induction.
Why is induction of programmed cell death important for drug discovery?
Because modulating the induction phase can selectively promote or prevent cell death in diseases such as cancer, stroke, and viral infections [1,2,5].
Conclusion
GO:0012502 (induction of programmed cell death) is a fundamental biological process that governs the initiation of cell death programs. Its relevance spans cancer, stroke, viral pathogenesis, and stem cell biology, making it a key focus for both basic and translational research [1,2,5,6,8]. By leveraging CRISPR-based models and advanced screening technologies, researchers can dissect the molecular mechanisms of death induction and identify new therapeutic targets. EDITGENE provides the tools and expertise to accelerate these discoveries.
References
- 1. Shkarina K et al.. 2024. Selective induction of programmed cell death using synthetic biology tools.. Semin Cell Dev Biol 156:74-92 PMID: 37598045
- 2. Gu L et al.. 2024. Single-cell and Spatial Transcriptomics Reveals Ferroptosis as The Most Enriched Programmed Cell Death Process in Hemorrhage Stroke-induced Oligodendrocyte-mediated White Matter Injury.. Int J Biol Sci 20(10):3842-3862 PMID: 39113700
- 3. Huang J et al.. 2022. Nobiletin as an inducer of programmed cell death in cancer: a review.. Apoptosis 27(5-6):297-310 PMID: 35312885
- 4. Jang JY et al.. 2022. Role of Induced Programmed Cell Death in the Chemopreventive Potential of Apigenin.. Int J Mol Sci 23(7) PMID: 35409117
- 5. Conrad M et al.. 2026. Cell death in cancer.. Cell 189(8):2322-2356 PMID: 41997127
- 6. Fujikura D et al.. 2018. Programmed Cell Death in the Pathogenesis of Influenza.. Int J Mol Sci 19(7) PMID: 30012970
- 7. Marianneau P et al.. 1998. Induction of programmed cell death (apoptosis) by dengue virus in vitro and in vivo.. Acta Cient Venez 49 Suppl 1:13-7 PMID: 10030049
- 8. Yamada Y et al.. 2024. Lethal and sublethal effects of programmed cell death pathways on hematopoietic stem cells.. Exp Hematol 134:104214 PMID: 38582294
